Massachusetts legislation · 194th General Court
Massachusetts H4951: An Act to address barriers to HIV prevention medication
Status: In committee, July 27, 2026
What the bill says
From the introduced text, January 28, 2026:
SECTION 1. Chapter 32A of the General Laws is hereby amended by inserting after section 17Z the following section:- Section 17AA: (a) As used in this section, the following words shall have the following meanings unless the context clearly requires otherwise:- “HIV”, human immunodeficiency virus. “HIV prevention drug”, any preexposure prophylaxis drug approved for the prevention of HIV by the federal Food and Drug Administration, including any ancillary or support health service determined by the secretary of health and human services that is necessary to: (1) ensure that such a drug is prescribed or administered to a person who is not infected with HIV and has no medical contraindications to the use of such a drug; and (2) monitor such a person to ensure the safe and effective ongoing use of such a drug through: (A) an office visit; (B) laboratory testing; (C) testing for a sexually transmitted infection; (D) medication self-management and adherence counseling; (E) or any other health service specified as part of comprehensive HIV prevention drug services by the United States Department of Health and Human Services, the United States Centers for Disease Control and Prevention or the United States Preventive Services Task Force, or an equivalent state-authorized body with responsibility to identify health services that are components of comprehensive HIV prevention drug services. (b) The commission …
Sponsors
- Services, Joint Committee on Financial (I) · primary sponsor
- John Moran (D, 9th Suffolk)
- Thomas Moakley (D)
- Jack Lewis (D, 7th Middlesex)
Latest actions
- : Committee recommended bill ought to pass and referred to the committee on House Ways and Means
- : Reporting date extended to Thursday, December 31, 2026
- : Reported favorably by committee and referred to the committee on Health Care Financing
- : New draft of H1245
- : Reported from the committee on Financial Services
Votes
- Committee Vote - Joint Committee on Health Care Financing (July 16, 2026): 13 yea, 0 nay, passed
- Committee Vote - Joint Committee on Financial Services (December 16, 2025): 11 yea, 0 nay, passed
Common questions
- What is H4951?
- H4951 is a bill in the Massachusetts Legislature (194th General Court): An Act to address barriers to HIV prevention medication.
- What is the status of H4951?
- In committee as of July 27, 2026. Latest action: Committee recommended bill ought to pass and referred to the committee on House Ways and Means (July 27, 2026).
- Who sponsored H4951?
- Services, Joint Committee on Financial (I), with 3 co-sponsors.
- Where is the official record for H4951?
- On the Massachusetts Legislature website: https://malegislature.gov/Bills/194/H4951
Source: official Massachusetts record. Tracked by Delilah, AI for legislation across all 50 states and Congress.